Randolf Kerschbaumer
Chief Executive Officer OncoOne
Randolf Kerschbaumer, CEO of OncoOne, brings over 25 years of experience from big pharma organizations and small biotech firms to the company. He acquired detailed knowledge of the entire drug development process, from early drug screening to clinical development. His intellectual curiosity, passion for science, and entrepreneurial drive allow him to effectively merge scientific innovation with strategic business planning. Prior to founding OncoOne, Randolf held several senior-level positions in R&D, focusing on therapeutics for cancer, inflammation, and hematologic disorders.
Seminars
Wednesday 25th February 2026
Pretargeting Strategies to Maximize Tumor Uptake & Minimize Normal-Tissue Exposure
11:45 am
- Allowing more radiation to reach the tumor while sparing healthy tissues
- Combining the strengths of antibodies (long circulation) with small molecules (fast clearance) for safer delivery
- Offering a path to more effective and tolerable treatments and addressing potential complexity in the clinic
New Company for 2026
